Navigation Links
Brazil Government In Contention With Merck Over Anti-AIDS Drug

The Brazil government is up against giant drug manufacturers- Merck &Co. The issue in contention is the pricey anti-AIDS drug Efavirenz. According to the Brazilian government, there is no call to charge as much as 1.59 US dollars for a 600mg pill when Thailand is paying 65 cents for the same.

Negotiations between Merck and the Brazilian government began last November. Last week the government declared the drug a public interest one. This means that Merck has just a few days to make the best out of a sticky situation. It will have to settle for a lower price of the drug or else face the chances of the drug being stripped of its patent or a compulsory license issued against it.

Meanwhile the Thai government has made a move dubbed a lifesaver, by its AIDS activists- the government has stripped the patents of three anti-AIDS drugs. In response to this, the United States has placed Thailand on a list of copyright violators .In Bangkok, AIDS activists rallied outside the U.S. Embassy on Thursday protesting the decision.

Meanwhile in Brazil, the government has already refused a discount by 30 percent of the drug. Said Merck spokeswoman Amy Rose: We at Merck were disappointed to have had what we consider to be a fair offer rejected by the government of Brazil. "We remain flexible, open and committed to the negotiations", she added.

The matter now will be referred to President Luiz Inacio Lula da Silva's chief of staff who will decide whether to issue the compulsory license and allow Brazil to manufacture the drug or to buy generic versions while paying Merck a small royalty.

Efavirenz is the drug most widely used by Brazil's anti-AIDS program, which provides free medication for anyone who needs it. Currently 75,000 of the 180,000 Brazilians who receive the free cocktail of anti-AIDS drug use efavirenz.

Victims of AIDS in the United States, who are so disabled by the disorder that they have to
'"/>




Page: 1 2

Related medicine news :

1. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
2. Brazilian Women to Be Vaccinated To Prevent Uterine Cancer
3. Malaria and TB Kills Indian Kids in Brazil
4. 13,000 Cases of Dengue Found in Brazil in January
5. Down Syndrome Dolls in Brazil After Child Actors Success
6. Brazil’s Claim to Fame - Fat Women and Drunk Men, Survey Find
7. Brazilian Boost for Bird Flu Vaccines
8. Brazil Will Purchase Merck’s Antiretroviral If Price Not Lowere
9. Brazil Spider Offers Hope for Those Suffering from Erectile Dysfunction
10. Brazil Government In Contention With Merck Over Anti-AIDS Drug
11. Brazil Opts for Indian Drugs Bypassing Merck

Post Your Comments:
(Date:12/1/2009)...RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire/ ...2001 and have expanded over the years serving the ...cility which was originally set up in an area of 2...ices, as part of the suite of services by Max Neem...s a valuable offering. ,, The pharmacy inventor...
(Date:12/1/2009)...SHINGTON, Dec. 1 Indivi...more likely than those with traditional coverage t... be more engaged in wellness programs, and to be m...tter in holding down costs, according to survey re...enefit Research Institute (EBRI). ,, At the sa...
(Date:12/1/2009)...ORT LAUDERDALE, Fla., Dec. 1 Orbus...rollment in the randomized clinical trial of the C... Stent). ,, A prospective, randomized, multicen...of an ablu M inal sirolimus coat ED bio- E ...p to 20 sites in Asia, Australia, Europe and South...
(Date:12/1/2009)...ients in California are unable to successfully obt...hospitals despite recent state legislation intende...w study. , Posing as low-income uninsured patien... than one-third of the hospitals they approached a...han those allowed under California law, according ...
(Date:12/1/2009)... Lumension announces general availabilit...e to deliver end-to-end endpoint management capabi... management console architecture. , ... -- Lumension, a global leader in endpoint managem...n® Endpoint Management and Security Suite (LEM...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
... Children,s Hospital UCLA have found that low-dose...the overall quality of life for adolescents suffer...he syndrome affects 6 percent of middle school stu... is the first of its kind to look at the effects o...
... In times of economic,uncertainty, engaging emplo...same time, becomes much more challenging. Engaged ...nization that employs them and that, in,turn, tran...ts into activities that drive employee engagement ...
...cial Guidance for Fiscal 2008 through 2010, PITTS...oday that it will host a conference call and live ...provide a review of the first,quarter ended March ...rck Generics, which the company acquired on,Oct. 2...
... A brand leader notes, "We make,decisions for the...." Brand,decisions must be made at the right time,...ximize the value of a brand., Brand Management ha...ore -- but that is fraught with potential,pitfalls...
...Illinois Residents to Say it out loud, CHICAGO, M...is residents is experiencing a mental health chall...ign was launched today to promote,good mental heal...lt in Illinois, lower the barriers that prevent pe...
...ION, WASHINGTON, May 1 The following media,advis...er(s):, Peter I. Buerhaus, PhD, RN, FAAN, Profess...inary Health Workforce Studies, Vanderbilt,Univers...th Ulrich, EdD, RN, FACHE, FAAN, Senior Vice Presi...
Other Medicine News:Health News:Antidepressant found to alleviate symptoms of irritable bowel syndrome in adolescents 2Health News:Complimentary Excerpt of Employee Engagement: Programs and Activities that Work Available from Best Practices 2Health News:Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008 2Health News:Best Practices in Designing Effective Brand Teams 2Health News:Making It Easier to Talk About Mental Health 2Health News:Making It Easier to Talk About Mental Health 3Health News:Making It Easier to Talk About Mental Health 4Health News:Will Nursing Shortage Cripple Future Health Care Plans? 2
(Date:12/1/2009)..., , TAI,AN, China, Dec. 1 /PR...s, Inc. (OTC Bulletin Board: CBPO) (Nasdaq: CBPO ... leading plasma-based biopharmaceutical companies ...eived approval to list its,common stock on the NAS...ts its shares to begin trading on the NASDAQ on,We...
(Date:12/1/2009)..., , BEIJING, Dec. 1 /PRNewswire...eading provider of biopharmaceutical products in C...rth purchase order for its H1N1 vaccine, PANFLU.1(...tion Technology for the national,purchase plan. Un...oduce an,additional one million doses of PANFLU.1 ...
(Date:12/1/2009)..., , ROCKVILLE, Md., Dec. 1 /PRNewswire-Fi...NDA ) announced today that the waiting period has ...t Improvements Act of 1976 with respect to Vanda,s...Pharma AG, and that the agreement is now effective...ting effectiveness of the agreement, triggers an u...
Breaking Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Light at the speed of a bicycle and much more 56500 1Light at the speed of a bicycle and much more 56500 2Sinapis Pharma Announces Frederick Frank as Consultant 56499 1Sinapis Pharma Announces Frederick Frank as Consultant 56499 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2
...rum Institut (SSI) and Intercell, report promisi...h a tuberculosis (TB) subunit vaccine , , »...ains Intercell’s,adjuvant IC31™ , , ...y the European Union aims to,either , repla...uo;Calmette vaccine” or,to , boost it...
... 15, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) to...n a novel nucleotide analog, GS 9219, which has sh...l studies, at the,2007 Annual Meeting of the Ameri...will take place in Los Angeles on April 14-18, 200...ly focused on,oncology, GS 9219 emerged from our e...
Other Medicine Technology:Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 2Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 4Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219,to be Presented at AACR 2Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219,to be Presented at AACR 3
Continuous Flow Cystoscopes
Prolieve™ Thermodilatation System
The Prostatron® System
...Targis® System uses Cooled ThermoTherapy® ... to deliver precisely targeted microwave energy de...ulative necrosis for durable clinical outcomes. Du...urethral and rectal temperatures for optimal thera...
Medicine Products: